Article Text

Download PDFPDF
Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care
  1. D A Turner1,
  2. S Paul2,
  3. M A Stone3,
  4. A Juarez-Garcia4,
  5. I Squire5,
  6. K Khunti3
  1. 1
    Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
  2. 2
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
  3. 3
    Division of General Practice & PHC, Department of Health Sciences, University of Leicester, Leicester, UK
  4. 4
    Health Services Management Centre, University of Birmingham, UK
  5. 5
    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
  1. David Turner, Wessex Institute for Health Research and Development, Mail point 728, Boldrewood, University of Southampton, Southampton SO16 7PX, UK; dturner{at}


Objective: To determine if a disease management programme for patients with coronary heart disease and heart failure represents an efficient use of health services resources.

Methods: We carried out an economic evaluation alongside a cluster randomised control trial of 1163 patients with coronary heart disease and chronic heart failure in 20 primary care practices in the United Kingdom. Practices were randomised to either a control group, where patients received standard general practice care, or an intervention group where patients had access to a specialist nurse-led disease management programme. We estimated costs in both groups for coronary heart disease-related resource use. The main outcome measure used in the economic evaluation was quality adjusted life years (QALY) measured using the EuroQol.

Results: The disease management programme was associated with an increase in the QALY measured of 0.03 per year and an increase in the total NHS costs of £425 (€540), of this only £83 was directly associated with the provision of the nurse clinics. The clinics generated additional QALY at an incremental cost of £13 158 per QALY compared to the control group.

Conclusions: The use of a nurse-led disease management programme is associated with increased costs in other coronary heart disease-related services as well as for the costs of the clinics. They are also associated with improvements in health. Even in the short term these disease management programmes may represent a cost-effective service, as additional QALY are generated at an acceptable extra cost.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: KK and IS have received sponsorship for attending conferences and small honoraria from pharmaceutical companies that make β-blockers, angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers.